This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

eReport

Pathophysiology, Patient Burden, and Recognition of OFF Episodes of Parkinson Disease

Rajesh Pahwa, MD, and Stuart H. Isaacson, MD

Published: October 27, 2020

This CME activity is expired. For more CME activities, visit CMEInstitute.com.
Find more articles on this and other psychiatry and CNS topics:
The Journal of Clinical Psychiatry
The Primary Care Companion for CNS Disorders


Abstract

The pathophysiology of PD has been elusive, but the motor symptoms of the disease are believed to result from a dopamine deficiency in the substantia nigra. As a patient’s disease progresses, OFF episodes emerge due to a shorter duration of response to levodopa treatment. OFF episodes include both motor and nonmotor symptoms, are common, and can occur at any time. OFF episodes can be predictable or unpredictable, significantly impact patient quality of life and functionality, and place a burden on families. By facilitating communication with patients and care partners using assessment tools, clinicians can detect symptoms of OFF episodes earlier.

From the University of Kansas, Kansas City (Dr Pahwa); and Parkinson’s Disease and Movement Disorders Center of Boca Raton, Florida (Dr Isaacson)

To cite: Isaacson S, Pahwa R. Pathophysiology, patient burden, and recognition of OFF episodes of Parkinson disease. J Clin Psychiatry. 2020;81(6):SU19004BR1C.

To share: https://doi.org/10.4088/JCP.SU19004BR1C

© Copyright 2020 Physicians Postgraduate Press, Inc.


Volume: 81

Quick Links: Neurologic and Neurocognitive , Parkinson Disease

References

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...

Read More...